New York State Common Retirement Fund’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.05M Buy
256,628
+213,715
+498% +$5.45M 0.01% 940
2025
Q4
$1.25M Sell
42,913
-5,757
-12% -$147K ﹤0.01% 1618
2025
Q3
$917K Hold
48,670
﹤0.01% 1721
2025
Q2
$682K Hold
48,670
﹤0.01% 1803
2025
Q1
$761K Buy
48,670
+23,503
+93% +$331K ﹤0.01% 1737
2024
Q4
$351K Hold
25,167
﹤0.01% 2063
2024
Q3
$234K Sell
25,167
-18,500
-42% -$183K ﹤0.01% 2217
2024
Q2
$406K Buy
43,667
+11,972
+38% +$108K ﹤0.01% 2121
2024
Q1
$314K Buy
31,695
+16,773
+112% +$125K ﹤0.01% 2264
2023
Q4
$48.2K Sell
14,922
-119
-0.8% -$323 ﹤0.01% 3009
2023
Q3
$79.9K Buy
15,041
+239
+2% +$2.03K ﹤0.01% 2834
2023
Q2
$141K Sell
14,802
-9,164
-38% -$102K ﹤0.01% 2649
2023
Q1
$264K Sell
23,966
-5,985
-20% -$86.6K ﹤0.01% 2478
2022
Q4
$443K Buy
29,951
+5,367
+22% +$93.8K ﹤0.01% 2370
2022
Q3
$470K Buy
24,584
+197
+0.8% +$4.46K ﹤0.01% 2353
2022
Q2
$520K Buy
24,387
+5,434
+29% +$111K ﹤0.01% 2354
2022
Q1
$365K Buy
18,953
+20
+0.1% +$338 ﹤0.01% 2543
2021
Q4
$393K Sell
18,933
-62
-0.3% -$1.23K ﹤0.01% 2559
2021
Q3
$454K Sell
18,995
-4,897
-20% -$112K ﹤0.01% 2518
2021
Q2
$652K Buy
23,892
+5,692
+31% +$160K ﹤0.01% 2456
2021
Q1
$527K Hold
18,200
﹤0.01% 2425
2020
Q4
$512K Buy
18,200
+8,800
+94% +$216K ﹤0.01% 2344
2020
Q3
$275K Hold
9,400
﹤0.01% 2510
2020
Q2
$284K Buy
+9,400
New +$272K ﹤0.01% 2490

Other funds holding ARQT